Hypoallergenic peanut closer to reality

Nut developed by A&T researchers moves closer to shelves

Originally published in the Winston-Salem Journal, 6/11/14

A peanut that might not trigger allergic reactions is one step closer to store shelves.

N.C. A&T announced Tuesday that it has signed a licensing deal with a Canadian firm. The company, Xemerge, will look for commercial applications for a hypoallergenic peanut developed by A&T researchers.

Read more...

  • Created on .

View news related to policies and regulations

Have news or an announcement to share? Contact Michelle Maclay at michelle_maclay@med.unc.edu

Get NC TraCS events and news delivered to your inbox! Subscribe to our weekly email blast

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact